Scopolamine patch

DRUG3 trials

Sponsors

Daniela Moga, Rutgers, The State University of New Jersey, University of California, Davis

Conditions

Alzheimer's DiseaseBariatric Surgery CandidateDementiaNauseaObesity, MorbidSatisfactionSurgeryVomiting

Early Phase 1

The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression

CompletedNCT02849639

Daniela MogaAlzheimer's Disease, Dementia

Start: 2017-04-04End: 2021-04-21Updated: 2023-07-19

Phase 4

Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section

CompletedNCT02960113

Rutgers, The State University of New JerseyNausea, Satisfaction, Vomiting

Start: 2016-05-31End: 2021-09-30Updated: 2022-12-28

Multimodal Analgesia Effect on Post Surgical Patient

Active, not recruitingNCT04240626

University of California, DavisBariatric Surgery Candidate, Obesity, Morbid, Surgery

Start: 2021-01-20End: 2026-06-24Updated: 2025-08-08

Related Papers

Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study

BMC Geriatrics2023-03-101 citations

INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol.

2019-12-3013 citations

P2‐572: INAPPROPRIATE MEDICATION USE ASSOCIATED WITH LOWER COGNITIVE RESERVE IN INDIVIDUALS WITH PRE‐CLINICAL ALZHEIMER'S DISEASE

Alzheimer s & Dementia2019-07-01